Sign in
STX Stock Price, Chart, Stats & News
Shield Therapeutics plc
Save
Shield Therapeutics plc (STX) does not currently pay a dividend.
52.94M
Market cap
–
Current P/E
227.27x
Forward P/E
STX chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Drug Manufacturers - Specialty & Generic
Industry
Shield Therapeutics plc, a commercial stage specialty pharmaceutical company, focuses on development and commercialization of clinical-stage pharmaceuticals to treat unmet medical needs. Its lead product is Accrufer/Feraccru, a non-salt based oral therapy for adults to treat the iron deficiency with or without anemia. Shield Therapeutics plc was incorporated in 2008 and is based in Gateshead, the United Kingdom.
Similar securities
Based on sector and market capitalization
Report issue